Back to First Trust Advisors LP First Trust Advisors LP

ACAD

31 quarters

Position history for First Trust Advisors LPFirst Trust Advisors LP's holdings in ACADIA Pharmaceuticals Inc.

Yes. First Trust holds 184,386 shares of ACAD (ACADIA Pharmaceuticals), worth $4.7M, as of its Q2 2026 13F filing. It reduced the position by 3,159,482 shares (-94.5%) from Q1 2026. First Trust has held ACAD in every 13F on record since Q4 2018, 31 quarterly filings.

Current Value

$4.7M

Current Shares

184,386

Total Value Change

-$62.3M

Total Shares Change

-4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
184,386
-94.5%
$4.7M0.0%$25.30
0
2026-Q1
Increased
3.3M
+47.3%
$74.4M0.1%$22.26
41
2025-Q4
Increased
2.3M
+16.8%
$60.6M0.0%$26.71
34
2025-Q3
Decreased
1.9M
-20.2%
$41.5M0.0%$21.34
0
2025-Q2
Increased
2.4M
+2.8%
$52.5M0.0%$21.57
30
2025-Q1
Decreased
2.4M
-12.3%
$39.3M0.0%$16.61
0
2024-Q4
Increased
2.7M
+27.0%
$49.5M0.0%$18.35
36
2024-Q3
Increased
2.1M
+2.8%
$32.7M0.0%$15.38
30
2024-Q2
Increased
2.1M
+25.4%
$33.6M0.0%$16.25
36
2024-Q1
Decreased
1.6M
-7.2%
$30.5M0.0%$18.49
0
2023-Q4
Increased
1.8M
+9.1%
$55.6M0.1%$31.31
32
2023-Q3
Decreased
1.6M
-35.0%
$33.9M0.0%$20.84
0
2023-Q2
Decreased
2.5M
-7.7%
$60M0.1%$23.95
0
2023-Q1
Decreased
2.7M
-5.8%
$51.1M0.1%$18.82
0
2022-Q4
Decreased
2.9M
-1.3%
$45.9M0.1%$15.92
0
2022-Q3
Increased
2.9M
+34.5%
$47.8M0.1%$16.36
38
2022-Q2
Decreased
2.2M
-6.9%
$30.6M0.0%$14.09
0
2022-Q1
Decreased
2.3M
-30.4%
$56.5M0.1%$24.22
0
2021-Q4
Increased
3.4M
+28.8%
$78.3M0.1%$23.34
37
2021-Q3
Decreased
2.6M
-11.0%
$43.2M0.0%$16.61
0
2021-Q2
Increased
2.9M
+85.4%
$71.3M0.1%$24.39
46
2021-Q1
Decreased
1.6M
-2.8%
$40.7M0.0%$25.80
0
2020-Q4
Decreased
1.6M
-5.5%
$86.7M0.1%$53.46
0
2020-Q3
Increased
1.7M
+20.9%
$70.8M0.1%$41.25
42
2020-Q2
Decreased
1.4M
-1.1%
$68.8M0.1%$48.47
0
2020-Q1
Increased
1.4M
+0.6%
$60.7M0.1%$42.25
35
2019-Q4
Decreased
1.4M
-43.5%
$61.1M0.1%$42.78
0
2019-Q3
Decreased
2.5M
-40.0%
$91.1M0.2%$35.99
0
2019-Q2
Decreased
4.2M
-12.4%
$112.8M0.2%$26.73
0
2019-Q1
Increased
4.8M
+16.4%
$129.3M0.3%$26.85
42
2018-Q4
First report
4.1M
-
$66.9M0.2%$16.17
0

Other major holders of ACAD: Baker Bros. Advisors LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used